摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Benzoyl-1,2-dihydropyridine | 91760-13-3

中文名称
——
中文别名
——
英文名称
N-Benzoyl-1,2-dihydropyridine
英文别名
phenyl(2H-pyridin-1-yl)methanone
N-Benzoyl-1,2-dihydropyridine化学式
CAS
91760-13-3
化学式
C12H11NO
mdl
——
分子量
185.225
InChiKey
NEVVIZQTDIGISA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    336.6±25.0 °C(Predicted)
  • 密度:
    1.149±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • Hydride Transfer from Iron(II) Hydride Compounds to NAD(P)<sup>+</sup> Analogues
    作者:Fanjun Zhang、Jiong Jia、Shuli Dong、Wenguang Wang、Chen-Ho Tung
    DOI:10.1021/acs.organomet.6b00179
    日期:2016.4.25
    Iron(II) hydride complexes of the "piano-stool" type, Cp*(P-P)FeH (P-P = dppe (1H) dppbz (2H), dppm (3H), dcpe (4H)) were examined as hydride donors in the reduction of N-benzylpyridinium and acridinium salts. Two pathways of hydride transfer, "single-step H-" transfer to pyridinium and a "two-step (e(-)/H-center dot)" transfer for acridinium reduction, were observed. When 1-benzylnicotinamide cation (BNA(+)) was used as an H- acceptor, kinetic studies suggested that BNA(+) was reduced at the C6 position, affording 1,6-BNAH, which can be converted to the more thermally stable 1,4-product. The rate constant k of H- transfer was very sensitive to the bite angle of P-Fe-P in Cp*(P-P)FeH and ranged from 3.23 X 10(-3) M-1 s(-1) for dppe to 1.74 X 10(-1) M-1 s(-1) for dppm. The results obtained from reduction of a range of N-benzylpyridinium derivatives suggest that H- transfer is more likely to be charge controlled. In the reduction of 10-methylacridinium ion (Acr(+)), the reaction was initiated by an e(-) transfer (ET) process and then followed by rapid disproportionation reactions to produce Acr(2) dimer and release of H-2. To achieve H-center dot transfer after ET from [Cp*(P-P)FeH](+) to acridine radicals, the bulkier acridinium salt 9-phenyl-10-methylacridinium (PhAcr(+)) was selected as an acceptor. More evidence for this "two-step (e(-)/H-center dot)" process was derived from the characterization of PhAcr(center dot) and [4H](+) radicals by EPR spectra and by the crystallographic structure confirmation of [4H](+). Our mechanistic understanding of fundamental H- transfer from iron(II) hydrides to NAD(+) analogues provides insight into establishing attractive bio-organometallic transformation cycles driven by iron catalysis.
  • WYLE, M. J.;FOWLER, F. W., J. ORG. CHEM., 1984, 49, N 21, 4025-4029
    作者:WYLE, M. J.、FOWLER, F. W.
    DOI:——
    日期:——
  • [EN] IMIDAZOLYL-SUBSTITUTED AZABENZOPHENONE COMPOUNDS<br/>[FR] COMPOSES D'AZABENZOPHENONE SUBSTITUES PAR IMIDAZOLYLE
    申请人:ALTANA PHARMA AG
    公开号:WO2007039578A1
    公开(公告)日:2007-04-12
    [EN] The compounds of formula (I) in which X, Y, R1 and R2 have the meanings as given in the description are novel effective inhibitors of the inducible nitric oxide synthase.
    [FR] Selon l'invention, les composés de formule (I), dans laquelle X, Y, R1 and R2 possèdent les significations données dans la description, constituent de nouveaux inhibiteurs efficaces de la synthase inductible de l'oxyde nitrique.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫